The patients serum was obtained 25 days after the sign onset. reinfections, is now of increasing concern. Furthermore, with the 1st generation of COVID-19 vaccines right now becoming delivered, the vaccine response of subjects receiving anti-CD20-depleting therapy is the next issue to be addressed for the appropriate individualization of vaccination Continue Reading